Bayer Stock Crashes After Monsanto Cancer Verdict Upheld By Judge; Analyst Estimates $800 Billion In Future Liability

Posted on:

Tuesday, October 23rd 2018 at 7:15 am

Written By:

Sayer Ji, Founder

This article is copyrighted by GreenMedInfo LLC, 2018
Visit our Re-post guidelines

 

Bayer greedily bought and swallowed the 'poison pill' of Monsanto without considering its true liability. Fifty-seven billion Euros of market cap down the drain later, now their headache is taking on epic proportions...

Growing uncertainty about whether San Francisco Superior Court Judge Suzanne Ramos Bolanos would rule in favor or against Bayer’s appeal of the Monsanto Cancer Verdict were resolved Tuesday morning as the judge upheld the jury’s decision that the glyphosate-based weedkiller (aka Roundup) sold by Monsanto caused a California man’s terminal cancer and that Monsanto intentionally hid its dangers.

The news quickly spread and caused an immediate crash in Bayer’s stock value, sending a powerful message to the Agrochemical industry that they are legally and financially responsible for the adverse effects caused by their unscrupulously marketed products despite receiving a regulatory pass from government agencies like the EPA, USDA, and FDA that have traditionally acted as industry cheerleaders.

The judge decided to reduce the punitive damage award from the original total of $289 million following a verdict reached earlier this summer, down to $78.5 million. A decision which concerned jurors who decided on the higher award amount in order to send a clear message to Monsanto that they deserve to be punished for covering up the dangers of their herbicide.

The good news is that this ruling affirms the company’s liability for causing illness from their product, and opens the door for more lawsuits and stricter regulation of agrochemicals in the future. Ian Hilliker, an analyst at Jefferies LLC in London, estimated in a note to clients that based on a class action lawsuit involving 8,700 plaintiffs believed to have cancer as a result of glyphosate exposure, Monsanto’s liability could reach $800 billion dollars. To put this in perspective, the original Bayer-Monsanto buyout offer was $57 billion dollars. Clearly, this no longer looks like an "asset" to Bayer and its stockholders.

In the tweet above, a German analyst points out that Bayer's Monsanto aquisition may have precipitated the largest destruction of market capitalization in German stock market history, standing at about 57.7 billion Euros in losses thus far.

Sources: 

• Wall Street Journal
• Bloomberg
• Health Impact News

Learn more about Bayer's history in the video below produced by independent media site Corbet Report: 

Note: The case is Johnson v. Monsanto Co., CGC-16-550128, California Superior Court, County of San Francisco (San Francisco).

Related Articles:

• Bayer Needs More Than an Aspirin to Cure its Monsanto-Sized Headache
  
• The Monsanto–Bayer tie-up is just one of seven; Mega-Mergers and Big Data Domination Threaten Seeds, Food Security
  

Sayer Ji is founder of Greenmedinfo.com, a reviewer at the International Journal of Human Nutrition and Functional Medicine, Co-founder and CEO of Systome Biomed, Vice Chairman of the Board of the National Health Federation, Steering Committee Member of the Global Non-GMO Foundation.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.

Internal Site Commenting is limited to members.
Disqus commenting is available to everyone.